Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Medical Oncology (Northwood, London, England)
|
May 3, 2014
Update on the molecular diagnosis and targeted therapy of thyroid cancer
Min Liu, Maomei Ruan, Libo Chen
Hellenic Journal of Nuclear Medicine
|
March 2, 2016
Challenges and strategies on radioiodine treatment for differentiated thyroid carcinoma
Lingxiao Cheng, Min Liu, Maomei Ruan, et al.
Oncology Letters
|
October 19, 2013
RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma
Maomei Ruan, Yan Shen, Libo Chen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 14, 2015
Iodide- and glucose-handling gene expression regulated by sorafenib or cabozantinib in papillary thyroid cancer
Maomei Ruan, Min Liu, Qianggang Dong, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 2, 2014
Notable decrease of malignant pleural effusion after treatment with sorafenib in radioiodine-refractory follicular thyroid carcinoma
Min Liu, Yan Shen, Maomei Ruan, et al.
Medicine
|
September 8, 2016
Increased 18F-FDG uptake of heterotopic pancreatitis in the small intestine: A CARE-compliant case report
Maomei Ruan, Min Liu, Lingxiao Cheng, et al.
Oncotarget
|
April 21, 2017
HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E
Lingxiao Cheng, Yuchen Jin, Min Liu, et al.
Scientific Reports
|
March 14, 2018
Predicting <sup>131</sup>I-avidity of metastases from differentiated thyroid cancer using <sup>18</sup>F-FDG PET/CT in postoperative patients with elevated thyroglobulin
Min Liu, Lingxiao Cheng, Yuchen Jin, et al.
Medicine
|
August 18, 2017
99mTc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from 131I therapy: A prospective observational study
Min Liu, Li Chai, Qiong Luo, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 19, 2018
Radioiodine Uptake and Thyroglobulin-Guided Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Prospective, Randomized, Open-Label, Controlled Trial
Yuchen Jin, Maomei Ruan, Lingxiao Cheng, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Medical Oncology (Northwood, London, England)
|
May 3, 2014
Update on the molecular diagnosis and targeted therapy of thyroid cancer
Min Liu, Maomei Ruan, Libo Chen
Hellenic Journal of Nuclear Medicine
|
March 2, 2016
Challenges and strategies on radioiodine treatment for differentiated thyroid carcinoma
Lingxiao Cheng, Min Liu, Maomei Ruan, et al.
Oncology Letters
|
October 19, 2013
RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma
Maomei Ruan, Yan Shen, Libo Chen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 14, 2015
Iodide- and glucose-handling gene expression regulated by sorafenib or cabozantinib in papillary thyroid cancer
Maomei Ruan, Min Liu, Qianggang Dong, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 2, 2014
Notable decrease of malignant pleural effusion after treatment with sorafenib in radioiodine-refractory follicular thyroid carcinoma
Min Liu, Yan Shen, Maomei Ruan, et al.
Medicine
|
September 8, 2016
Increased 18F-FDG uptake of heterotopic pancreatitis in the small intestine: A CARE-compliant case report
Maomei Ruan, Min Liu, Lingxiao Cheng, et al.
Oncotarget
|
April 21, 2017
HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E
Lingxiao Cheng, Yuchen Jin, Min Liu, et al.
Scientific Reports
|
March 14, 2018
Predicting <sup>131</sup>I-avidity of metastases from differentiated thyroid cancer using <sup>18</sup>F-FDG PET/CT in postoperative patients with elevated thyroglobulin
Min Liu, Lingxiao Cheng, Yuchen Jin, et al.
Medicine
|
August 18, 2017
99mTc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from 131I therapy: A prospective observational study
Min Liu, Li Chai, Qiong Luo, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 19, 2018
Radioiodine Uptake and Thyroglobulin-Guided Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Prospective, Randomized, Open-Label, Controlled Trial
Yuchen Jin, Maomei Ruan, Lingxiao Cheng, et al.
Page
of 3